MedTrace Logo

Burst Biologics Foot and Ankle Registry

NCT03077256 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2019-05-28

No results posted yet for this study

Summary

This prospective registry was designed as an observational study to ascertain how commercially available Burst Products are being used by foot and ankle surgeons performing procedures which involve bone grafting, as well as determining relevant patient outcomes.

Conditions

  • Foot and Ankle Disorders
  • Ankle Fusion, Osteotomy

Interventions

DEVICE

BioBurst Fluid, Burst Allograft

BioBurst Fluid, Burst Allograft in Foot and Ankle Surgery

Sponsors & Collaborators

  • Burst Biologics

    lead INDUSTRY

Principal Investigators

  • Steven M Czop, R.Ph. · Medical Affairs Officer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-24
Primary Completion
2020-07-01
Completion
2020-10-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03077256 on ClinicalTrials.gov